Greta L Lundgaard
Overview
Explore the profile of Greta L Lundgaard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patel M, Peltier H, Matulenko M, Koenig J, Scanio M, Gum R, et al.
Bioorg Med Chem
. 2022 Apr;
63:116743.
PMID: 35436748
The voltage-gated sodium channel Na1.7 is an attractive target for the treatment of pain based on the high level of target validation with genetic evidence linking Na1.7 to pain in...
2.
Frost J, Degoey D, Shi L, Gum R, Fricano M, Lundgaard G, et al.
J Med Chem
. 2016 Mar;
59(7):3373-91.
PMID: 27015369
The genetic validation for the role of the Nav1.7 voltage-gated ion channel in pain signaling pathways makes it an appealing target for the potential development of new pain drugs. The...
3.
Lundgaard G, Daniels N, Pyndiah S, Cassimere E, Ahmed K, Rodrigue A, et al.
J Cell Biochem
. 2011 Jun;
112(10):2992-3001.
PMID: 21678469
Bridging integrator 1 (BIN1) is a nucleocytoplasmic adaptor protein with tumor suppressor properties. The protein interacts with and inhibits the c-MYC transcription factor through the BIN1 MYC-binding domain (MBD). However,...
4.
Harrison B, Huynh K, Lundgaard G, Helmke S, Perryman M, McKinsey T
FEBS Lett
. 2010 Mar;
584(6):1103-10.
PMID: 20188095
Class IIa histone deacetylases (HDACs) -4, -5, -7 and -9 undergo signal-dependent nuclear export upon phosphorylation of conserved serine residues that are targets for 14-3-3 binding. Little is known of...